The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,022.00
Bid: 2,020.00
Ask: 2,024.00
Change: 20.00 (1.00%)
Spread: 4.00 (0.198%)
Open: 2,014.00
High: 2,026.00
Low: 2,014.00
Prev. Close: 2,002.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Doc re. Bond Guarantor Group

6 May 2016 09:12

RNS Number : 4851X
Hikma Pharmaceuticals Plc
06 May 2016
 

6 May 2016

 NOTICE OF ACCESSION OF GUARANTORS

Hikma Pharmaceuticals Public Limited Company(the "Issuer")

 

Notice to the holders of the outstanding

U.S.$500,000,000 4.25 per cent. Guaranteed Notes due 2020 (ISIN: XS1213834978)

(the "Notes")

 

The Issuer refers to (i) the terms and conditions of the Notes (the "Conditions") set out in the prospectus dated 8 April 2015 relating to the Notes and (ii) a deed of guarantee dated 10 April 2015 between the Issuer and Arab Pharmaceutical Manufacturing PSC, Eurohealth (USA), Inc., Hikma Farmacêutica (Portugal) S.A., Hikma Pharmaceuticals LLC and West-Ward Pharmaceutical Corp. (together, the "Original Guarantors") in favour of the Holders and the Relevant Account Holders (each as defined therein) (the "Deed of Guarantee").

Capitalised terms used in this Notice and not defined herein shall have the meanings set out in the Conditions and the Deed of Guarantee.

NOTICE IS HEREBY GIVEN that, pursuant to and in compliance with the provisions of Condition 5.7 (Guarantor Group) and the Deed of Guarantee, as of 29 April 2016 each of the subsidiaries of the Issuer listed in the Schedule to this Notice has, in each case, pursuant to an accession deed of guarantee dated 29 April 2016 (each an "Accession Deed of Guarantee") and an accession deed of covenant dated 29 April 2016, become a Guarantor and agreed to:

(i) perform and observe all the obligations expressed to be undertaken by a Guarantor under the Conditions, the Deed of Guarantee, a deed of covenant between the Issuer and the Original Guarantors dated 10 April 2015 (the "Deed of Covenant") and a fiscal agency agreement between, among others, the Issuer, the Original Guarantors and Citbank, N.A. London Branch dated 10 April 2015 ("the Fiscal Agency Agreement"), and each agrees that it shall be bound by the Conditions, the Deed of Guarantee, the Deed of Covenant and the Fiscal Agency Agreement in all respects as if it had been an original party thereto; and

(ii) jointly and severally with all the Original Guarantors, unconditionally and irrevocably guarantee the payment of all sums expressed to be payable by the Issuer in respect of the Notes to Holders and Relevant Account Holders.

Copies of each Accession Deed of Guarantee (and the documents described therein) are available for inspection at the office of Hikma Pharmaceuticals Public Limited Company.Schedule 

Name of New Guarantor

Registration

Address

Roxane Laboratories, Inc. (entity number E0034412005-8)

Registered in the state of Nevada

1809 Wilson RoadColumbus

OH 43228United States

West-Ward Columbus Inc (file number 863458)

Registered in the state of Delaware

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DOCUGUUGAUPQURQ
Date   Source Headline
11th Jun 20143:11 pmRNSDirector/PDMR Shareholding
10th Jun 20145:13 pmRNSTotal Voting Rights
29th May 20149:45 amRNSDirector/PDMR Shareholding
29th May 20149:40 amRNSDirector/PDMR Shareholding
28th May 201412:00 pmRNSAcquisition
27th May 20149:53 amRNSDirector/PDMR Shareholding
15th May 20143:05 pmRNSResults of AGM
15th May 20147:00 amRNSInterim Management Statement
6th May 20141:03 pmRNSDirector/PDMR Shareholding
17th Apr 20144:41 pmRNSAnnual Information Update
14th Apr 20145:28 pmRNSDirector/PDMR Shareholding
7th Apr 20145:28 pmRNSBlocklisting Interim Review
7th Apr 20144:27 pmRNSTotal Voting Rights
2nd Apr 20147:00 amRNSSuccessful resolution to US FDA warning letter
24th Mar 201410:23 amRNSDirector/PDMR Shareholding
12th Mar 20147:10 amRNSDirectorate Change
12th Mar 20147:00 amRNSFinal Results
27th Feb 20142:35 pmRNSNotification of major interests in shares
21st Feb 201410:24 amRNSBlock Listing of Shares
14th Feb 20147:00 amRNSTrading Statement
30th Dec 20139:50 amRNSDirector/PDMR Shareholding
20th Dec 20134:23 pmRNSDirector/PDMR Shareholding
20th Dec 20131:58 pmRNSDirector/PDMR Shareholding
16th Dec 20137:00 amRNSTotal Voting Rights
13th Dec 20137:00 amRNSHolding(s) in Company
20th Nov 20137:00 amRNSRe Agreement
11th Nov 20134:55 pmRNSDirector/PDMR Shareholding
8th Nov 20133:04 pmRNSDirector/PDMR Shareholding
8th Nov 20137:00 amRNSInterim Management Statement
25th Oct 20134:13 pmRNSDirector/PDMR Shareholding
23rd Oct 201311:40 amRNSHolding(s) in Company
18th Oct 20134:55 pmRNSDirector/PDMR Shareholding
4th Oct 20132:01 pmRNSDividend Declaration
1st Oct 201311:27 amRNSBlocklisting Interim Review
1st Oct 201311:22 amRNSTotal Voting Rights
18th Sep 20137:00 amRNSHikma entering Ethiopian pharmaceutical market
2nd Sep 20133:06 pmRNSTransaction in Own Shares
29th Aug 201311:10 amRNSTransaction in Own Shares
21st Aug 20137:00 amRNSInterim Results
31st Jul 20133:41 pmRNSDirector/PDMR Shareholding
19th Jul 20139:40 amRNSTotal Voting Rights
8th Jul 20137:00 amRNSTrading Statement
5th Jul 20134:21 pmRNSHolding(s) in Company
1st Jul 20137:00 amRNSSigning of Exclusive Agreement with Theravance
20th Jun 20133:16 pmRNSDirector/PDMR Shareholding
3rd Jun 201311:24 amRNSTotal Voting Rights
28th May 20135:24 pmRNSHolding(s) in Company
23rd May 20134:59 pmRNSDirector/PDMR Shareholding
21st May 20133:36 pmRNSDirector/PDMR Shareholding
20th May 20139:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.